The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial
Open accessAbstract
OBJECTIVE: To compare breast cancer incidence and mortality up to 25 years in women aged 40-59 who did or did not undergo mammography screening. DESIGN: Follow-up of randomised screening trial by centre coordinators, the study's central office, and linkage to cancer registries and vital statistics databases. SETTING: 15 screening centres in six Canadian provinces,1980-85 (Nova Scotia, Quebec, Ontario, Manitoba, Alberta, and British Columbia). PARTICIPANTS: 89,835 women, aged 40-59, randomly assigned to mammography (five annual mammography screens) or control (no mammography). INTERVENTIONS: Women aged 40-49 in the mammography arm and all women aged 50-59 in both arms received annual physical breast examinations. Women aged 40-49 in the control arm received a single examination followed by usual care in the community. MAIN OUTCOME MEASURE: Deaths from breast cancer. RESULTS: During the five year screening period, 666 invasive breast cancers were diagnosed in the mammography arm (n=44,925 participants) and 524 in the controls (n=44,910), and of these, 180 women in the mammography arm and 171 women in the control arm died of breast cancer during the 25 year follow-up period. The overall hazard ratio for death from breast cancer diagnosed during the screening period associated with mammography was 1.05 (95% confidence interval 0.85 to 1.30). The findings for women aged 40-49 and 50-59 were almost identical. During the entire study period, 3250 women in the mammography arm and 3133 in the control arm had a diagnosis of breast cancer, and 500 and 505, respectively, died of breast cancer. Thus the cumulative mortality from breast cancer was similar between women in the mammography arm and in the control arm (hazard ratio 0.99, 95% confidence interval 0.88 to 1.12). After 15 years of follow-up a residual excess of 106 cancers was observed in the mammography arm, attributable to over-diagnosis. CONCLUSION: Annual mammography in women aged 40-59 does not reduce mortality from breast cancer beyond that of physical examination or usual care when adjuvant therapy for breast cancer is freely available. Overall, 22% (106/484) of screen detected invasive breast cancers were over-diagnosed, representing one over-diagnosed breast cancer for every 424 women who received mammography screening in the trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Bleyer, A., & Welch, H. G. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206809 · Cited by 1,367
Miller, A. B., Baines, C. J., To, T. M., & Wall, C. (1992) · Europe PMC (PubMed Central) · Cited by 864
Self-citationTabár, L., Vitak, B., Chen, T. H.-H., Yen, A. M.-F., Cohen, A., Tot, T., Chiu, S. Y.-H., Chen, S. L.-S., Fann, J. C.-Y., Rosell, J., et al. (2011) · Radiology · doi:10.1148/radiol.11110469 · Cited by 791
Miller, A. B. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1490 · Cited by 512
Self-citationPeriodic Breast Cancer Screening in Reducing Mortality From Breast Cancer
Shapiro, S. (1971) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1971.03180240027005 · Cited by 499
Miller, A. B., To, T., Baines, C. J., & Wall, C. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_1-200209030-00005 · Cited by 394
Self-citationZackrisson, S., Andersson, I., Janzon, L., Manjer, J., & Garne, J. P. (2006) · BMJ · doi:10.1136/bmj.38764.572569.7c · Cited by 341
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Bleyer, A., & Welch, H. G. (2013) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3182978e4a · Cited by 244
The Emperor of all Maladies: A Biography of Cancer
Huilgol, N. (2011) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.80439 · Cited by 239
Tumour Size Predicts Long-Term Survival among Women with Lymph Node-Positive Breast Cancer
Narod, S. A. (2012) · Current Oncology · doi:10.3747/co.19.1043 · Cited by 98
Self-citation
Cited by
Breast-Cancer Screening — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Benbrahim-Tallaa, L., Bouvard, V., Bianchini, F., & Straif, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1504363 · Cited by 962
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., Brawley, O. W., & Wender, R. C. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21392 · Cited by 719
Benefits and Harms of Breast Cancer Screening: A Systematic Review
Myers, E. R., Moorman, P., Gierisch, J. M., Havrilesky, L. J., Grimm, L. J., Ghate, S., Davidson, B., Mongtomery, R. C., Crowley, M. J., McCrory, D. C., et al. (2015) · JAMA · doi:10.1001/jama.2015.13183 · Cited by 637
Nelson, H. D., Fu, R., Cantor, A., Pappas, M., Daeges, M., & Humphrey, L. (2016) · Annals of Internal Medicine · doi:10.7326/m15-0969 · Cited by 611
Fenton, J. J., Weyrich, M. S., Durbin, S., Liu, Y., Bang, H., & Melnikow, J. (2018) · JAMA · doi:10.1001/jama.2018.3712 · Cited by 555
Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review
Guo, R., Lu, G., Qin, B., & Fei, B. (2018) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2017.09.012 · Cited by 542
Smith, R. A., Manassaram-Baptiste, D., Brooks, D., Cokkinides, V., Doroshenk, M., Saslow, D., Wender, R. C., & Brawley, O. W. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21212 · Cited by 478
A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions
Pace, L. E., & Keating, N. L. (2014) · JAMA · doi:10.1001/jama.2014.1398 · Cited by 461
Single-breath-hold photoacoustic computed tomography of the breast
Lin, L., Hu, P., Shi, J., Appleton, C. M., Maslov, K., Li, L., Zhang, R., & Wang, L. V. (2018) · Nature Communications · doi:10.1038/s41467-018-04576-z · Cited by 454
Smith, R. A., Manassaram‐Baptiste, D., Brooks, D., Doroshenk, M., Fedewa, S., Saslow, D., Brawley, O. W., & Wender, R. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21261 · Cited by 451
Nelson, H. D., Pappas, M., Cantor, A., Griffin, J., Daeges, M., & Humphrey, L. (2016) · Annals of Internal Medicine · doi:10.7326/m15-0970 · Cited by 410
Using publication metrics to highlight academic productivity and research impact
Carpenter, C. R., Cone, D. C., & Sarli, C. C. (2014) · Academic Emergency Medicine · doi:10.1111/acem.12482 · Cited by 377
Benefits and harms of mammography screening
Løberg, M., Lousdal, M. L., Bretthauer, M., & Kalager, M. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0525-z · Cited by 368
Screening for Cancer in Low- and Middle-Income Countries
Sankaranarayanan, R. (2014) · Annals of Global Health · doi:10.1016/j.aogh.2014.09.014 · Cited by 296
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines
Schünemann, H. J., Lerda, D., Quinn, C., Follmann, M., Alonso-Coello, P., Rossi, P. G., Lebeau, A., Nyström, L., Broeders, M., Ioannidou-Mouzaka, L., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m19-2125 · Cited by 286
Mandelblatt, J. S., Stout, N. K., Schechter, C. B., van den Broek, J. J., Miglioretti, D. L., Krapcho, M., Trentham-Dietz, A., Munoz, D., Lee, S. J., Berry, D. A., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1536 · Cited by 281
The WISDOM Study: breaking the deadlock in the breast cancer screening debate
Esserman, L. J., the WISDOM Study and Athena Investigators, Anton-Culver, H., Borowsky, A., Brain, S., Cink, T., Crawford, B., Eklund, M., Esserman, L., Fenton, J., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0035-5 · Cited by 272
Lennon, A. M., Wolfgang, C. L., Canto, M. I., Klein, A. P., Herman, J. M., Goggins, M., Fishman, E. K., Kamel, I., Weiss, M. J., Diaz, L. A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0734 · Cited by 262
Field, J. K., Vulkan, D., Davies, M. P. A., Baldwin, D. R., Brain, K. E., Devaraj, A., Eisen, T., Gosney, J., Green, B. A., Holemans, J. A., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100179 · Cited by 230
Smartphone breast applications – What's the evidence?
Mobasheri, M. H., Johnston, M., King, D., Leff, D., Thiruchelvam, P., & Darzi, A. (2014) · The Breast · doi:10.1016/j.breast.2014.07.006 · Cited by 137
Krstic, M., Kolendowski, B., Cecchini, M. J., Postenka, C. O., Hassan, H. M., Andrews, J., MacMillan, C. D., Williams, K. C., Leong, H. S., Brackstone, M., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5245 · Cited by 34
Ciarrochi, J., Zettle, R. D., Brockman, R., Duguid, J., Parker, P., Sahdra, B., & Kashdan, T. B. (2015) · The Wiley Handbook of Contextual Behavioral Science · doi:10.1002/9781118489857.ch16 · Cited by 20
Metadata
- Authors
- Miller, A. B., Wall, C., Baines, C. J., Sun, P., To, T., & Narod, S. A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2014-02-11
- Volume
- 348
- Issue
- feb11 9
- Pages
- g366-g366
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2163735782
- Cited by
- 702
- References
- 13
- FWCI
- 59.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.